Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC34091102496;102497;102498 chr2:178534344;178534343;178534342chr2:179399071;179399070;179399069
N2AB3245097573;97574;97575 chr2:178534344;178534343;178534342chr2:179399071;179399070;179399069
N2A3152394792;94793;94794 chr2:178534344;178534343;178534342chr2:179399071;179399070;179399069
N2B2502675301;75302;75303 chr2:178534344;178534343;178534342chr2:179399071;179399070;179399069
Novex-12515175676;75677;75678 chr2:178534344;178534343;178534342chr2:179399071;179399070;179399069
Novex-22521875877;75878;75879 chr2:178534344;178534343;178534342chr2:179399071;179399070;179399069
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: CGG
  • RefSeq wild type template codon: GCC
  • Domain: Kinase-1
  • Domain position: 279
  • Q(SASA): 0.3625
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/Q rs763708375 -0.193 None N None 0.195 0.146414634003 gnomAD-2.1.1 3.23E-05 None None None None N None 8.27E-05 8.49E-05 None 0 0 None 6.54E-05 None 0 1.57E-05 0
R/Q rs763708375 -0.193 None N None 0.195 0.146414634003 gnomAD-3.1.2 3.94E-05 None None None None N None 4.83E-05 0 0 0 0 None 0 0 4.41E-05 2.07039E-04 0
R/Q rs763708375 -0.193 None N None 0.195 0.146414634003 gnomAD-4.0.0 7.07026E-05 None None None None N None 6.67735E-05 8.335E-05 None 0 2.22787E-05 None 0 0 8.56058E-05 1.09784E-05 1.60113E-05
R/W rs140319117 -0.302 None N None 0.328 None gnomAD-2.1.1 1.01552E-03 None None None None N None 3.30852E-04 1.35793E-03 None 3.00097E-03 0 None 6.54E-05 None 4.19E-05 1.43289E-03 1.40687E-03
R/W rs140319117 -0.302 None N None 0.328 None gnomAD-3.1.2 9.7976E-04 None None None None N None 2.41476E-04 1.2459E-03 0 2.59665E-03 0 None 9.44E-05 0 1.52896E-03 4.1425E-04 1.91205E-03
R/W rs140319117 -0.302 None N None 0.328 None 1000 genomes 7.98722E-04 None None None None N None 0 1.4E-03 None None 0 3E-03 None None None 0 None
R/W rs140319117 -0.302 None N None 0.328 None Lange (2005) Lange (2014) None HMERF comp het with P31732L None None N WGS prioritisation in 2 Swedish families; greatly reduces interaction of kinase with nbr1; nbr1 and MuRF1 show diffuse localisation; comp het with Fn3-119 variants, re-classified as benign; subsequent argument it may be modulatory to incompletely penetrant P31732L variant None None None None None None None None None None None
R/W rs140319117 -0.302 None N None 0.328 None gnomAD-4.0.0 1.37625E-03 None None None None N None 2.66667E-04 1.35018E-03 None 2.83784E-03 2.22856E-05 None 4.7957E-05 1.48466E-03 1.62993E-03 1.31749E-04 1.37657E-03

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.8825 likely_pathogenic 0.907 pathogenic -1.081 Destabilizing None None None None None None None None N
R/C 0.6514 likely_pathogenic 0.7263 pathogenic -0.863 Destabilizing None None None None None None None None N
R/D 0.9656 likely_pathogenic 0.9657 pathogenic -0.251 Destabilizing None None None None None None None None N
R/E 0.8031 likely_pathogenic 0.8233 pathogenic -0.056 Destabilizing None None None None None None None None N
R/F 0.9486 likely_pathogenic 0.9631 pathogenic -0.524 Destabilizing None None None None None None None None N
R/G 0.7636 likely_pathogenic 0.763 pathogenic -1.472 Destabilizing None None None None N 0.428445869 None None N
R/H 0.4073 ambiguous 0.4526 ambiguous -1.72 Destabilizing None None None None None None None None N
R/I 0.7973 likely_pathogenic 0.8696 pathogenic 0.009 Stabilizing None None None None None None None None N
R/K 0.2361 likely_benign 0.2486 benign -0.819 Destabilizing None None None None None None None None N
R/L 0.7399 likely_pathogenic 0.7989 pathogenic 0.009 Stabilizing None None None None N 0.426712286 None None N
R/M 0.826 likely_pathogenic 0.8772 pathogenic -0.381 Destabilizing None None None None None None None None N
R/N 0.9356 likely_pathogenic 0.9415 pathogenic -0.576 Destabilizing None None None None None None None None N
R/P 0.9467 likely_pathogenic 0.9377 pathogenic -0.335 Destabilizing None None None None N 0.427752436 None None N
R/Q 0.2702 likely_benign 0.3257 benign -0.535 Destabilizing None None None None N 0.428272511 None None N
R/S 0.9052 likely_pathogenic 0.9221 pathogenic -1.363 Destabilizing None None None None None None None None N
R/T 0.8067 likely_pathogenic 0.858 pathogenic -0.943 Destabilizing None None None None None None None None N
R/V 0.8598 likely_pathogenic 0.908 pathogenic -0.335 Destabilizing None None None None None None None None N
R/W 0.6435 likely_pathogenic 0.6908 pathogenic -0.116 Destabilizing None None None None N 0.428792586 None None N
R/Y 0.867 likely_pathogenic 0.8931 pathogenic 0.107 Stabilizing None None None None None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.